aluminum sulfate has been researched along with Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arashkia, A; Goradel, NH; Malekshahi, ZV; Mohajel, N; Negahdari, B; Shirazi, MMA | 1 |
| Bian, MM; Du, JJ; Guo, J; Li, YT; Liu, YL; Wang, J; Wen, Y; You, ZW; Zhang, RY; Zhou, SH | 1 |
| Cui, Y; Feng, W; Jiang, H; Li, S; Liu, S; Liu, Y; Shi, W; Zhang, H | 1 |
| Cuzzubbo, S; Habra, K; Mangsbo, S; McArdle, SEB; Nagarajan, D; Pockley, AG | 1 |
| Fan, Y; Huang, R; Li, M; Lu, L; Men, K; Tian, Y; Xu, H; Yang, L; Yu, C; Yuan, F; Zhang, R; Zhang, X; Zhou, B | 1 |
| Cheng, C; Deng, L; Li, R | 1 |
| Maughan, CN; Preston, SG; Williams, GR | 1 |
| Shi, Y; Wen, Y | 1 |
| Ishii, KJ; Kuroda, E; Temizoz, B | 1 |
| Bhattachary-Chatterjee, M; Chakraborty, M; Chatterjee, SK; Das, R; Foon, KA; Nath Baral, R; Zeytin, H | 1 |
5 review(s) available for aluminum sulfate and Neoplasms
| Article | Year |
|---|---|
Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments.
Topics: Adjuvants, Immunologic; Age Factors; Alum Compounds; Antineoplastic Agents; Cancer Vaccines; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cytokines; Drug Synergism; Emulsions; Gastrointestinal Microbiome; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Immunotherapy, Active; Life Style; Liposomes; Lymphocyte Depletion; Membrane Proteins; Nanoparticles; Neoplasms; Radiotherapy; Saponins; Toll-Like Receptors; Vaccine Potency; Virosomes | 2020 |
Particulate inorganic adjuvants: recent developments and future outlook.
Topics: Adjuvants, Immunologic; Alum Compounds; Humans; Immunity, Cellular; Metals; Neoplasms; Vaccines | 2015 |
Alum: an old dog with new tricks.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Hepatitis B; Humans; Inflammasomes; Neoplasms; NLR Family, Pyrin Domain-Containing 3 Protein; Vaccines | 2016 |
Vaccine adjuvants as potential cancer immunotherapeutics.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Cancer Vaccines; Clinical Trials as Topic; Humans; Immunomodulation; Immunotherapy; Lectins, C-Type; Neoplasms; Oligodeoxyribonucleotides; Vaccination | 2016 |
Counterpoint. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Breast Neoplasms; Cancer Vaccines; Carcinoembryonic Antigen; Clinical Trials as Topic; Colorectal Neoplasms; Epitopes; Evaluation Studies as Topic; Gangliosides; Glycolipids; Glycoproteins; Humans; Immunization; Leukemia-Lymphoma, Adult T-Cell; Lipid Droplets; Melanoma; Mice; Mice, Inbred C57BL; Models, Immunological; Molecular Mimicry; Neoplasms; Neoplasms, Experimental; Treatment Outcome | 2000 |
1 trial(s) available for aluminum sulfate and Neoplasms
| Article | Year |
|---|---|
Counterpoint. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Breast Neoplasms; Cancer Vaccines; Carcinoembryonic Antigen; Clinical Trials as Topic; Colorectal Neoplasms; Epitopes; Evaluation Studies as Topic; Gangliosides; Glycolipids; Glycoproteins; Humans; Immunization; Leukemia-Lymphoma, Adult T-Cell; Lipid Droplets; Melanoma; Mice; Mice, Inbred C57BL; Models, Immunological; Molecular Mimicry; Neoplasms; Neoplasms, Experimental; Treatment Outcome | 2000 |
5 other study(ies) available for aluminum sulfate and Neoplasms
| Article | Year |
|---|---|
Heterologous administration of HPV16 E7 epitope-loaded nanocomplexes inhibits tumor growth in mouse model.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antigens; Cancer Vaccines; CD8-Positive T-Lymphocytes; Disease Models, Animal; Epitopes; Immunization; Mice; Neoplasms; Oligodeoxyribonucleotides; Papillomavirus E7 Proteins; T-Lymphocytes, Cytotoxic; Vaccination; Vaccine Efficacy | 2021 |
Alum Adjuvant and Built-in TLR7 Agonist Synergistically Enhance Anti-MUC1 Immune Responses for Cancer Vaccine.
Topics: Adjuvants, Immunologic; Alum Compounds; Aluminum Hydroxide; Animals; Cancer Vaccines; Glycopeptides; Immunity; Mice; Mucin-1; Neoplasms; Toll-Like Receptor 7 | 2022 |
Ferroptosis and Necroptosis Produced Autologous Tumor Cell Lysates Co-Delivering with Combined Immnoadjuvants as Personalized
Topics: Antigens; Cancer Vaccines; Ferroptosis; Humans; Immunotherapy; Necroptosis; Neoplasms; Tumor Microenvironment | 2023 |
The novel complex combination of alum, CpG ODN and HH2 as adjuvant in cancer vaccine effectively suppresses tumor growth in vivo.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antigens; Cancer Vaccines; Cell Line, Tumor; Cell Proliferation; Cytokines; Disease Models, Animal; Humans; Immunization; Lymphocytes, Tumor-Infiltrating; MAP Kinase Signaling System; Mice; Neoplasms; NF-kappa B; Oligodeoxyribonucleotides; p38 Mitogen-Activated Protein Kinases; Peptides; T-Lymphocyte Subsets; Tumor Burden; Vaccination; Xenograft Model Antitumor Assays | 2017 |
The Immunogenicity and Anti-Tumor Efficacy of a Rationally Designed EGFR Vaccine.
Topics: Alum Compounds; Amino Acid Sequence; Animals; Antibodies; Base Sequence; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cytokines; Diphtheria Toxin; Enzyme-Linked Immunosorbent Assay; Epitopes; ErbB Receptors; Female; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms; Oligodeoxyribonucleotides; Peptides; Th1 Cells; Transplantation, Heterologous | 2018 |